| Bid Price | 0.09p | High Price | 0.11p |
|---|
| Ask Price | 0.10p | Low Price | 0.09p |
|---|
| Open Price | 0.09p | Spread | 10.00% |
|---|
| Prev Close | 0.09p | Volume | 45,333,141 |
|---|
Nuformix PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Mar 21, 2025 | 0.09 | 0.11 | 0.09 | 0.10 | 45,333,141 |
| Mar 20, 2025 | 0.10 | 0.11 | 0.08 | 0.09 | 150,826,279 |
| Mar 19, 2025 | 0.07 | 0.11 | 0.07 | 0.10 | 84,617,280 |
| Mar 18, 2025 | 0.08 | 0.09 | 0.07 | 0.07 | 20,608,453 |
| Mar 17, 2025 | 0.08 | 0.08 | 0.08 | 0.08 | 4,628,943 |
Nuformix PLC Information
| Name | Nuformix PLC | Index | |
|---|
| ISIN | GB00BYW79Y38 | Epic | NFX |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSQ3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 2,000,000 | Trading Status | Closed |
|---|
| Shares in Issue | 1.67 bn | Prev Close | 0.09p |
|---|
| PE Ratio | | Market Cap | £1.59 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.231901 | Quick Ratio | 0.119325 |
|---|
Nuformix PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 05/11/24 | PLAC | Daniel Gooding | RES | 12,000,000 @ £0.00 | £6,000.00 |
| 05/11/24 | PLAC | Madeleine Kennedy | NED | 22,000,000 @ £0.00 | £11,000.00 |
| 05/11/24 | PLAC | Julian Gilbert | NED | 22,000,000 @ £0.00 | £11,000.00 |
| 10/01/22 | BUY | Alastair Riddell | RES | 400,000 @ £0.01 | £4,700.00 |
| 16/09/21 | BUY | Alastair Riddell | RES | 350,000 @ £0.01 | £4,725.00 |
| 30/03/21 | PLAC | Karl Keegan | RES | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Madeleine Kennedy | NED | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Julian Gilbert | NED | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Anne Brindley | RES | 500,000 @ £0.02 | £10,000.00 |
| 05/02/20 | SELL | David Tapolczay | RES | 650,000 @ £0.09 | £56,550.00 |
Nuformix PLC News
